Pre-operative chemoimmunotherapy in lung cancer – a new promising approach for stage III tumours.
The Lancet Oncology is to publish the results of the NADIM study from the Spanish Lung Cancer Group (SLCG), which paves the way for a change in the therapeutic approach to intermediate-stage lung cancer. World-leading Spanish investigations yield survival results that double those previously obtained with standard, postoperative chemotherapy. This is the first advance in […]